Your Daily Pharma Scoop: Valeant Value Trap, Agenus Upside, Celgene s Potential – vrx, Seeking Alpha, valeant pharma.#Valeant #pharma

Posted On May 8 2018 by

valeant pharma Avisol Capital Partners Your Daily Pharma Scoop: Valeant Value Trap, Agenus Upside, Celgene s Potential Oct. 24, 2017 3:21 PM • vrx Today, we discuss an article on Valeant and see if it is a value trap. What’s the actual monetary upside for Agenus for GSK’s Shingrix approval? Celgene has catalysts. This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Please click here or scroll down below to read an important announcement about changes and additions to the daily scoop. Analysis of …


Turbidity, Coriolis Pharma, archimedes pharma.#Archimedes #pharma

Posted On May 8 2018 by

Turbidity Among the various analytical services provided by Coriolis Pharma, turbidity measurements are offered. Turbidimetry is the measurement of light transmitted through a sample solution. The transmitted light can be measured in a UV-Vis spectrophotometer at a wavelength where the ingredients, such as proteins, peptides, DNA/RNA, and formulation excipients (e.g., amino acids) do not absorb light, i.e., typically in the range of 320 800 nm. Clarity and degree of opalescence of samples is measured according to the Ph. Eur. method described under 2.2.1 of the Ph. Eur. 7 th edition. Clarity values are assigned based on comparative measurements against reference …


Evaluate pharma, evaluate pharma.#Evaluate #pharma

Posted On May 8 2018 by

Innovative biotechnologies: bacteriophages against infections Pherecydes Pharma is the first Company to have launched a multicenter european phage therapy trial according to Western pharmaceutical and clinical standards, to evaluate phage therapy on infected burn wounds. The first patient was enroled on July 2015 in France. Bacteriophages: natural viruses of bacteria They are harmless to eukaryote organisms (humans, animals, fishes, plants, insects, algae’s, etc). When they recognize their bacterial target, they attach to its outer membrane, inject their genetic material and reproduce in their host to make new phages that get out and repeat the same cycle. The lytic phages, those …


Drug Research by Pharmaceutical Startup Firms, cubist pharma.#Cubist #pharma

Posted On May 8 2018 by

Big Pharma Creating Startup Firms to Do Drug Research Written by Shawn Radcliffe on October 11, 2017 Pfizer and other pharmaceutical companies are investing in independent startups, hoping to find the next popular and profitable drug. Pharmaceutical companies are trying to capture a little bit of the startup magic. Pfizer and several other firms have invested in a small spinoff company that will develop drug therapies for underserved patients. With $103 million in initial funding, SpringWorks Therapeutics will focus at first on therapies for post-traumatic stress disorder (PTSD) and three rare forms of cancer. Pfizer owns the rights to the …


Baltimore Engineering Consulting Firm: Kibart, Inc: MEP Engineering: Towson, MD, mgi pharma.#Mgi #pharma

Posted On May 8 2018 by

Kibart MEP Engineers Mechanical / Electrical Engineers Mechanical Engineering Learn More Master Planning Learn More LEED-Certified Design Learn More Utility and Infrastructure Learn More Featured Projects Cowan Systems Wake Forest Innovation Quarter Vane Brothers Shepherd University Washington Co. Regional Library Creekstone Village Our Expertise in Action Always Putting the Client First. Clients count on Kibart for solutions that are creative, contemporary, reliable and sustainable. We are an MEP engineering and commissioning firm that works collaboratively with all project stakeholders. Because we are disciplined in our continuing education, and in cross-training our teams, we have developed exceptionally relevant expertise in the …


Fenofibrate Alternatives, sciele pharma.#Sciele #pharma

Posted On May 8 2018 by

Fenofibrate Alternatives An Introduction to Fenofibrate Alternatives Decrease LDL and total cholesterol levels Increase HDL cholesterol. Fenofibrates Lipofen [package insert]. Montgomery, AL: Kowa Pharmaceuticals America, Inc.;2008 June. Fenoglide [package insert]. San Diego, CA: Santarus, Inc.;2012 October. Antara [package insert]. Waltham, MA: Oscient Pharmaceuticals Corporation;2006 September. Lofibra capsules [package insert]. Sellersville, PA: Gate Pharmaceuticals;2003 July. Lofibra tablets [package insert]. Sellersville, PA: Gate Pharmaceuticals;2005 July. Tricor [package insert]. North Chicago, IL: Abbott Laboratories;2004 November. Triglide [package insert]. Atlanta, GA: Sciele Pharma, Inc.;2005 November.


TRELSTAR – (triptorelin pamoate for injectable suspension), Palliative Treatment for Advanced Prostate Cancer, watson pharma.#Watson #pharma

Posted On May 8 2018 by

watson pharma You are now leaving an Allergan website. A link to a non-Allergan website does not constitute an endorsement of the products or services offered by the non-Allergan website, and Allergan is not responsible for the content of any non-Allergan website. Thank you for visiting You are now leaving an Allergan website. A link to a non-Allergan website does not constitute an endorsement of the products or services offered by the non-Allergan website, and Allergan is not responsible for the content of any non-Allergan website. Thank you for visiting You are now leaving an Allergan website. A link to …


Pharma Skeletons, jazz pharma.#Jazz #pharma

Posted On May 8 2018 by

Pharma Skeletons Welcome to Pharma Skeletons, by Martin Shkreli. Email [email protected] Abbott still raises the price of Humira, every year. This is despite Humira being the best selling drug on the planet. Allergan pretends 10% price increases make sense in a no-inflation environment. Just assume no one can do math. A big price increase on a small product is worse than small increases on big products, right? But everyone else is the bad actor, not us. Don’t forget the inversion to avoid taxes, as well as their attempt to reverse merge with Pfizer to take them out of the U.S. …


EcoTensil ™, Creators of EcoTaster (tasting spoon) and SpoonLidz ™ Sustainable, biodegradable Utensils, Award winning future-friendly utensils, nexgen pharma.#Nexgen #pharma

Posted On May 8 2018 by

nexgen pharma the eating utensil EcoTensil products are Using less material is the ultimate way to be more sustainable EcoTensil products are silky smooth and sturdy, like a paper soda cup Our on-package utensils bring together the two opposing trends of grab-and-go convenience and waste reduction A word from our customers. “We LOVE EcoTasters! We use them at all our tasting events and get great comments about them. ‘Wow! these are neat!’ ” — Brown Dog Mustard Co. “The customer response to EcoTaster was overwhelmingly positive and the demo specialists absolutely loved them.” — Melissa Taverse, Demo Program Coordinator, Whole …


Xynomic Pharma Acquires Global Rights of Boehringer Ingelheim – s BI 882370, a Novel and Potent RAF, royalty pharma.#Royalty #pharma

Posted On May 8 2018 by

Xynomic Pharma Acquires Global Rights of Boehringer Ingelheim’s BI 882370, a Novel and Potent RAF Inhibitor against Solid Tumors News provided by Oct 30, 2017, 12:25 ET Share this article CHEYENNE, Wyo., Oct. 30, 2017 /PRNewswire/ — Xynomic Pharma, a clinical stage US oncology drug development company, today announced that it has acquired exclusive global rights to develop, manufacture and commercialize BI 882370, a 2nd-generation RAF inhibitor, from Boehringer Ingelheim, a top-20 global pharmaceutical company. Under the terms of the agreement Xynomic will pay upfront, milestone and royalty payments up to approximately $502 million . BI 882370 is a potent …